The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia
1 - 2 December 2020
Online
Deputy Head of the Division for Coordination of Work on Pharmaceutical Drugs and Medical Devices Circulation, Department for Technical Regulation and Accreditation
Eurasian Economic Commission
Deputy Director of the Department for Pharmaceutical Drug Provision and Regulation of the Circulation of Medical Devices
Ministry of Health of the Russian Federation
Deputy Director in Supervision over preclinical testings and clinical trials of medicines and medicinial products departmenr
Federal Service for Surveillance in Healthcare
Head
Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise "Center for Examinations and Tests in Health Service"
Associate Professor of the Department of Therapy, Clinical Pharmacology and Ambulance
Moscow State Medical University
Head of the Department for Pre-Clinical and Clinical Trials
National Medical Research Centre of Oncology Named after N.N.Petrov
Head of department of clinical trials
Sechenov University
Site Relationship Partner (Director), Russia and Belarus
Pfizer
Chief Scientific Officer
Novartis Pharma, Russia
Data Generation & Scientific Communication Lead, Medical Affairs
Sanofi
Medical devices department lector
RMANPO
Chief Medical Officer
R-Pharm
Country Head of Site Management
Bayer
Head of Medical Projects Group
Takeda
Medical director
IPHARMA
Director, Project Management
Statandocs
Compliance Process, Training & Systems Manager, PDG Country Clinical Operations, CEETRISMEA
F.Hoffmann-La Roche Ltd.
Managing Director
ZM Company Inc
Clinical Research Manager
GlaxoSmithKline
Director of Clinical Research & Medical Affairs
AIPM Russia
Medical Director
Servier
Deputy director for medical work
FSBI National Medical Research Center of Oncology named after N.N. Blokhin "of the Ministry of Health of Russia
Executive Director
Good Clinical Practice Alliance - Europe (GCPA), Belgium
Senior Medical Advisor
Novartis
Director
Sciencefiles
Oncologist
Russian Railways Clinical Hospital (Saint Petersburg)
Head of Pharmacovigilance
R-Pharm
Clinical Trials Director, Russia & EAEU countries
Servier
Head of laboratory medicine, head of clinical immunology laboratory
FSBI NMRRC of the Ministry of Health of the Russian Federation
Deputy Director of Clinical Research
AstraZeneca
Chairman
INTERNATIONAL UNION FOR PATIENT ASSISTANCE AND SUPPORT
Independent GCP / GLP Auditor
Head of the Department of Clinical Pharmacology
Yaroslavl State Medical University
Cardiologist, Advisor to the General Director
International Medical Cluster
Head of the Clinical Pharmacology Laboratory
St. Petersburg Pavlov First Saint Petersburg State Medical University
Registration Engineer Lead
Elamed
Head of oncology department
Russian Railways Clinical Hospital
Head of department of bioethics
Pirogov Medical University
Head of Medical Department
Petrovax
Head of chemotherapy dedpartment
FSBI National Medical Research Center of Oncology named after N.N. Blokhin "of the Ministry of Health of Russia
Quality and Compliance Manager
Janssen
Director
Statandocs
Director, Institute for Personalized Medicine
Health Management Clinic, Sechenov University
Independent Clinical Quality Assurance Consultant
The QARP project, TowerMains
In order to manage and comply with travel and social distancing restrictions, the “Clinical Trials in Russia” Forum will be hosted virtually on a FULLY INTERACTIVE ONLINE PLATFORM.
Stream sessions with leading Clinical Trials practitioners and ask your questions to speakers in real time!
Meet new partners and digitally connect with key market players – via online chat, email and video calls!
Join the event directly from your laptop, tablet or smartphone – and save on time, money and travel!
KEY TOPICS & FEATURES IN 2020:
o The current status of the clinical trials market: what are the latest trends in Russia and globally?
o Clinical trials during the Covid-19 pandemic: practical experiences, challenges and solutions found
o Clinical trials in the Eurasian Union - registration practices and common rules in action
o Acceleration of digitalisation in clinical trials: AI, remote monitoring, electronic registers, access to data and data safety
o RWE - globally and in Russia: RWE as a key tool for the federal project “Digital technologies”
o Live Interviews with sponsors and research & investigators centres
Insights from 40+ experts: regulators, representatives of international and Russian pharmaceutical producers, CROs and investigators
2-day information-rich programme that includes insightful presentations from leading sector players, interactive debates and round tables
Unrivalled networking opportunities with 150+ attendees from such companies as AstraZeneca, Pfizer, Novartis, Bayer, Biocad, R-Pharm and many more
Unique opportunity for all the clinical trials sector players to meet and discuss the most burning issues.
The forum brings together representatives of all stakeholder groups involved in clinical trials – sponsors, CROs, regulators and investigators for a constructive dialogue aimed at improving all future processes.
Very good overview of a large number of clinical trial topics and the specifics of the Russian market.
Very interesting insight into the latest developments in the Russian market.
